Natural Products Association filed a Citizen's Petition on cbdMD's (NYSE:YCBD) behalf with the Food and Drug Administration (FDA) requesting it remove the drug exclusion for CBD and review the company's extensive dossier of identity, safety and quality data.
Removing the drug exclusion for CBD will achieve clarity in the market and create a level playing field for all participants. The final outcome of this process is expected to result in the ability of the cbdMD to submit and receive acknowledgment for a new dietary ingredient notification. This will allow the company to inform consumers of the benefits of its CBD products and expand sales in the United States by opening up mass retail channels.
